Be aware that it is a net number. Having seen other such trailing commissions structures for drugs the internal ongoing costs the company puts on th edrug are astonishing ( marketing , junkets the full works and % of corporate costs etc etc) and until those ongoing costs Nadda comes home and then all the development costs are paid backso nothing flows for quite a period IMO. We will never see the fine print. .
Generic competition at much lower price changes market bit other side is a better drug regimine in patent will command a high price if it has signifiicant inprovement in dosage , effectiveness or side affects . Uptake and insurance companies can be slow as well or fast if it is ecconomically better.
- Forums
- ASX - By Stock
- Double or Triple?
Be aware that it is a net number. Having seen other such...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
0.001(1.08%) |
Mkt cap ! $38.73M |
Open | High | Low | Value | Volume |
9.4¢ | 9.6¢ | 9.2¢ | $11.66K | 123.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28393 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.6¢ | 2593 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28393 | 0.093 |
1 | 247718 | 0.092 |
1 | 48440 | 0.091 |
2 | 80000 | 0.090 |
1 | 400000 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.096 | 2593 | 1 |
0.098 | 19848 | 1 |
0.099 | 630 | 1 |
0.100 | 52000 | 2 |
0.105 | 92396 | 2 |
Last trade - 14.37pm 03/07/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online